×







We sell 100% Genuine & New Books only!

High-Risk IV Medications in Special Patient Populations 1st Editon 2011 Hardbound at Meripustak

High-Risk IV Medications in Special Patient Populations 1st Editon 2011 Hardbound by Sandra Kane-Gill, Joseph Dasta, Springer

Books from same Author: Sandra Kane-Gill, Joseph Dasta

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 13887.00/- [ 15.00% off ]

    Seller Price: ₹ 11804.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Sandra Kane-Gill, Joseph Dasta
    PublisherSpringer
    Edition1st Edition
    ISBN9780857296054
    Pages160
    BindingHardbound
    LanguageEnglish
    Publish YearJuly 2011

    Description

    Springer High-Risk IV Medications in Special Patient Populations 1st Editon 2011 Hardbound by Sandra Kane-Gill, Joseph Dasta

    Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions. Anesthetic agents (general, inhaled, intravenous).- Propofol, ketamine, etc.- Anti-infectives.- aminoglycosides, vancomycin, drotrecogin, amphotericin products.- inhaled agents.- Anticoagulants agents.- unfractionated heparin, low molecular weight heparins, fondaparinux, lepirudin, argatroban, bivalrudin, abciximab, eptifibatide, tirofiban.- Thrombolytics –reteplase, tenecteplase, streptokinase, urokinase, alteplase.- Cardiac Drugs.- Adrenergic agents.- dopamine, dobutamine, vasopressin, , nitroglycerin, nitroprusside epinephrine, norepinepherine, phenylepherine.- Adrenergic antagonists.- Propranolol, diltiazem, verapamil, esmolol, labetalol, clevidipine.- Antidyrrhthmics.- amiodarone, lidocaine, procainamide.- Inotropic agents.- milrinone, amrinone, isoproterenol, niseritide, digoxin.- Prostanoids.- Epoprostenol, iloprost, treprostenil.- Electrolytes.- Potassium, magnesium, sodium chloride (hypertonic), cardioplegic solutions.- Hypoglycemics.- Insulin and oral agents.- Neuromuscular blocking agents .- vecuronium, rocuronium, cisatracurium, atracurium, succinylcholine.- Opioids (IV, oral).- Remifentanyl, fentanyl , morphine, hydromorphone, meperidine.- Sedatives (IV, oral and transdermal).- lorazepam, midazolam, diazepam, propofol, dexmedetomidine.- Information for Each Drug.- Propofol .- Normal.- Obese.- Renal Dysfunction.- CrCL.- Dialysis (HD, CRRT).- Liver Dysfunction.- Recommendations for Safe Use.



    Book Successfully Added To Your Cart